Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Appointed director
Notes underwriting agrmnt
|
|
Kura Oncology, Inc. (KURA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
4
| Powl Brian T. (Chief Commercial Officer) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 200,000 options to buy
@ $11.72, valued at
$2.3M
|
|
| 08/16/2023 |
3
| Powl Brian T. (Chief Commercial Officer) has filed a Form 3 on Kura Oncology, Inc. |
| 06/02/2023 |
4
| WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Disposed of 8,394 shares
@ $0
Acquired 8,394 shares
@ $0
Disposed of 41,318 shares
@ $0
Disposed of 212,500 shares
@ $0
Disposed of 300,000 shares
@ $0
Acquired 300,000 shares
@ $0
Disposed of 27,966 shares
@ $0 |
|
| 06/02/2023 |
4
| Szela Mary T (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 26,000 options to buy
@ $13.32, valued at
$346.3k
|
|
| 06/02/2023 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 26,000 options to buy
@ $13.32, valued at
$346.3k
|
|
| 06/02/2023 |
4
| Parks Diane L. (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 26,000 options to buy
@ $13.32, valued at
$346.3k
|
|
| 06/02/2023 |
4
| Malley Thomas (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 26,000 options to buy
@ $13.32, valued at
$346.3k
|
|
| 06/02/2023 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 26,000 options to buy
@ $13.32, valued at
$346.3k
|
|
| 06/02/2023 |
4
| Collins Helen Louise (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 26,000 options to buy
@ $13.32, valued at
$346.3k
|
|
| 02/21/2023 |
4
| DOYLE THOMAS JAMES (SVP, Finance & Accounting) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 10,625 shares
@ $0
Granted 63,750 options to buy
@ $11.99, valued at
$764.4k
|
|
| 02/21/2023 |
4
| Bair Teresa Brophy (Chief Legal Officer) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 23,125 shares
@ $0
Granted 138,750 options to buy
@ $11.99, valued at
$1.7M
|
|
| 02/21/2023 |
4
| FORD KATHLEEN (COO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 185,000 options to buy
@ $11.99, valued at
$2.2M
|
|
| 02/21/2023 |
4
| DALE STEPHEN (Chief Medical Officer) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 23,125 shares
@ $0
Granted 185,000 options to buy
@ $11.99, valued at
$2.2M
|
|
| 02/21/2023 |
4
| WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Disposed of 468,297 shares
@ $0
Disposed of 17,708 shares
@ $0
Disposed of 41,318 shares
@ $0
Acquired 41,318 shares
@ $0
Disposed of 1,084,300 shares
@ $0
Acquired 1,084,300 shares
@ $0
Disposed of 11,985 shares
@ $0
Granted 560,000 options to buy
@ $11.99, valued at
$6.7M
|
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Bair Teresa Brophy (Chief Legal Officer) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Sold 2,100 shares
@ $15.2212, valued at
$32k
|
|
| 06/23/2022 |
4
| Collins Helen Louise (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 23,000 options to buy
@ $14.84, valued at
$341.3k
|
|
| 06/23/2022 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 23,000 options to buy
@ $14.84, valued at
$341.3k
|
|
| 06/23/2022 |
4
| Parks Diane L. (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 23,000 options to buy
@ $14.84, valued at
$341.3k
|
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Stein Steven H (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 23,000 options to buy
@ $14.84, valued at
$341.3k
|
|
| 06/23/2022 |
4
| Malley Thomas (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 23,000 options to buy
@ $14.84, valued at
$341.3k
|
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| DOYLE THOMAS JAMES (SVP, Finance & Accounting) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 8,390 shares
@ $0
Granted 39,281 options to buy
@ $13.14, valued at
$516.2k
|
|
| 02/09/2022 |
3
| DOYLE THOMAS JAMES (SVP, Finance & Accounting) has filed a Form 3 on Kura Oncology, Inc. |
| 01/28/2022 |
4
| GRASSO MARC (CFO, CBO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 21,900 shares
@ $0
Granted 131,000 options to buy
@ $14.15, valued at
$1.9M
|
|
| 01/28/2022 |
4
| FORD KATHLEEN (COO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 21,900 shares
@ $0
Granted 171,000 options to buy
@ $14.15, valued at
$2.4M
|
|
| 01/28/2022 |
4
| FLOWERS KIRSTEN (Chief Commercial Officer) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 21,900 shares
@ $0
Granted 171,000 options to buy
@ $14.15, valued at
$2.4M
|
|
| 01/28/2022 |
4
| DALE STEPHEN (Chief Medical Officer) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 36,900 shares
@ $0
Granted 261,000 options to buy
@ $14.15, valued at
$3.7M
|
|
| 01/28/2022 |
4
| WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 495,000 options to buy
@ $14.15, valued at
$7M
|
|
| 10/19/2021 |
4
| Bair Teresa Brophy (Chief Legal Officer) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 192,000 options to buy
@ $17.51, valued at
$3.4M
|
|
|
|
|